ΝΕΑ

Therapeutic Efficacy of Autologous Blood‑Derived Stem Cells with Growth Factors in Moderate to Severe Alzheimer’s Disease: A Clinical Trial

Miracell Demonstrates Cognition Impairment and Brain Function Improvement in Severe Alzheimer’s Patients Using SMART M-CELL-Based CD34+ Cell-Rich Autologous Blood Concentrate

MIRACELL Products Receive FDA Clearance

The FDA 510(k) clearance was obtained for the integrated system combining the extraction device with blood and bone marrow kits,

MIRACELL ATHENS Announces EUDAMED Registration

Regulatory Update — EUDAMED Registration (SRN) MIRACELL ATHENS is now registered in the European Database on Medical Devices (EUDAMED) under

Interview in Budapest, for Miracell Hungary

Many thanks to all our marvellous friends of MIRACELL HUNGARY for their superb hosting.

Official Registration of MIRACELL Products with the GREEK NATIONAL ORGANISATION FOR MEDICINES (ΕΟΦ)

MIRACELL ATHENS P.C.C. announced that as of February 25th, 2026, all MIRACELL products are officially registered with the Greek National

Presentation At The IFFAS 2025 Fall: Biological Age Reversal Study

Presentation, Questions And Answers At The IFFAS 2025 Fall: Biological Age Reversal Through Integrative Treatment and CD34+ Stem Cell Therapy:

Interview By The Korean National Broadcast Television SBS News: Insights From Biological Age Reversal Lecture

My Deep Gratitude To The People Of The Great Nation Of Korea. My Eternal Honour And Pride To Work With

Interview At The Soonchunhyang University Hospital of Seoul: Understanting Therapy With CD34+ Stem Cells

A Marvellous Opportunity To Visit The Astonishing Soonchunhyang University Hospital of Seoul And Talk About The Divine Cells. Many Thanks

IFFAS 2025 Fall Presentation

Biological Age Reversal Through Integrative Treatment and CD34+ Stem Cell Therapy: A Quantitative Analysis by The Stem Cell Clinic by